Cooper Companies | COO - Pre Utilidad Fiscal





Pre Utilidad Fiscal Cambio Fecha
Abbott USD 2.39B 27M 2026-03
Align Technology USD 148.89M 27.71M 2026-03
AtriCure USD 394K 1.97M 2026-03
Avanos Medical USD 1.2M 2.4M 2025-12
Bausch Health Companies USD 56M 162M 2025-12
Baxter International USD -756M 877M 2025-12
Bayer EUR -1.16B 735M 2025-09
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 700M 238M 2025-12
Cooper Companies USD 116.8M 137.4M 2025-09
Dentsply International USD -147M 83M 2025-12
Dexcom USD 340.7M 40.7M 2025-12
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Globus Medical USD 143.99M 44.18M 2025-09
Haemonetics USD 59.97M 8.69M 2025-12
Inogen USD -6.06M 467K 2024-09
Insulet USD 140.2M 17.4M 2025-12
Integra LifeSciences USD 4.31M 11.13M 2025-12
Intuitive Surgical USD 955.6M 100.4M 2025-12
J&J USD 7.82B 2.86B 2026-03
Medtronic USD 2.1B 224M 2025-09
Merit Medical Systems USD 51.06M 22.12M 2025-12
Novartis USD 5.17B 637M 2025-09
ResMed USD 496.15M 13.77M 2025-12
STAAR Surgical USD 18.79M 44.7M 2025-09
Steris USD 324.4M 92.5M 2025-09
Stryker USD 1.7B 676M 2025-12
Tandem Diabetes Care USD -25.14M 32.58M 2025-09
Teleflex USD -438.58M 573.82M 2025-09
Utah Medical Products 418K 3K 2024-09
Zimmer Biomet Holdings USD 98M 320.7M 2025-12